HBx-elevated SIRT2 promotes HBV replication and hepatocarcinogenesis

Area of Science:

• Hepatology
• Molecular Biology
• Oncology

Background:

• Sirtuin 2 (SIRT2) is a class III histone deacetylase implicated in hepatocellular carcinoma (HCC) development.
• The role of SIRT2 in Hepatitis B virus (HBV) infection and its contribution to HCC pathogenesis remains unclear.

Purpose of the Study:

• To investigate the functional role of SIRT2 in HBV infection and HBV-mediated HCC.
• To elucidate the mechanism by which HBV influences SIRT2 expression and activity.

Main Methods:

• Analysis of SIRT2 expression in HBV-infected cells and tissues.
• Investigation of the effect of HBx on SIRT2 promoter activity, mRNA, and protein levels.
• Assessment of SIRT2's role in HBV transcription and replication.
• Evaluation of SIRT2's contribution to hepatocarcinogenesis in the context of HBV infection.

Main Results:

• Hepatitis B virus (HBV) infection upregulates Sirtuin 2 (SIRT2) expression.
• The HBV protein HBx activates the SIRT2 promoter, increasing SIRT2 mRNA and protein levels.
• SIRT2 facilitates HBV transcription and replication.
• HBx-induced upregulation of SIRT2 promotes hepatocarcinogenesis in HBV-mediated HCC.

Conclusions:

• SIRT2 plays a novel and critical role in HBV infection and HBV-mediated HCC.
• SIRT2 promotes HBV replication and HBx-elevated SIRT2 enhances the transformation of HBV-mediated HCC.
• SIRT2, particularly through its interaction with HBx, represents a potential therapeutic target for HBV-related liver cancer.